PTEN and breast carcinoma: Treatment of mouse-derived breast cancer 4T1 cells with 200 or 500 nmol/L VO-OHpic for 1–4 h inhibited PTEN mRNA and protein levels, with particularly notable effects after treatment for 2–4 h, especially for PTEN protein (Figures 1A, B).